Voluntary announcement receiving the certificate of registration of proprietary chinese medicine

Summary by 6ix AI

Tong Ren Tang Technologies Co. Ltd. has announced that its subsidiary received a Certificate of Registration for a proprietary Chinese medicine, allowing it to be sold in Hong Kong. The medicine, named Dingzhi Wan, is intended to supplement qi and nourish the heart, addressing various health concerns. The company has invested significantly in the research and development of this product, which has not yet been launched for sale. The certificate is expected to aid in expanding the company's product lines and market presence, though it will not have an immediate material impact on operations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries